MICHAELA MILLER: Open Payments
NPI 1427688365 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 32 payments from 14 companies in 2025. Trend: 2023 $580 · 2024 $406 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| PFIZER INC. | 3 | $84 |
| Lilly USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 3 | $67 |
| Organon LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Abbott Laboratories | 1 | $24 |
| GENZYME CORPORATION | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: EOHILIA, NURTEC ODT, MOUNJARO, VRAYLAR, Ozempic, NEXPLANON, QULIPTA, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
